MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Amylin and insulin in Parkinson’s disease patients: a clinical and metabolic study

    A. Sánchez-Gómez, M. Fernández, G. Alcarraz, R. Fernández, M. Ezquerra, A. Cámara, A. Novials, E. Muñoz, F. Valldeoriola, Y. Compta, MJ. Martí (Barcelona, Spain)

    Objective: To assess the possible connection between PD and glucose metabolism (GM) by analyzing the levels of biomarkers of GM in patients with PD. Background:…
  • 2019 International Congress

    THOR 201: A Proof-of-Concept Study Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of L-dopa delivered by Impel’s Precision Olfactory Delivery (PODTM) to Parkinson’s Disease Patients in an OFF Episode (in the presence of Dopa Decarboxylase Inhibitor)

    S. Shrewsbury, J. Campbell, M. Swardstrom, A. Lehn, K. Satterly, J. Hoekman (Seattle, WA, USA)

    Objective: Impel NeuroPharma has developed the patient-friendly, self or caregiver actuatedPrecision Olfactory Delivery (IMPEL PODTM) device to achieve consistent upper nasal cavity drug delivery, rapid…
  • 2019 International Congress

    Body Mass Gain in Parkinson’s Disease Following Deep Brain Stimulation: A Systematic Review

    J. Steinhardt, T. Münte, S. Schmid, B. Wilms, N. Brüggemann (Lübeck, Germany)

    Objective: To investigate the extent and time course of body mass gain after subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson’s disease (PD) patients.…
  • 2019 International Congress

    Does Anticholinergic Burden Affect the Outcomes in Patients Diagnosed with Parkinson’s Disease?

    S. Taylor, E. Jones (York, United Kingdom)

    Objective: To explore the impact of an anticholinergic burden on various outcomes in Parkinson’s disease. Background: Over 600 different medications possess some anticholinergic effect.[1] There…
  • 2019 International Congress

    Functional mobility tests and their relationship with disease stage in patients with Parkinson’s Disease

    B. üğüt, T. Kahraman, A. Kalkan, A. Genç, B. çolakoğlu (Izmir, Turkey)

    Objective: The main objective of this study is set as to determine the relationship between several Functional Mobility Tests (FMT) and disease stages in patients…
  • 2019 International Congress

    Camptocormia in Parkinson’s disease – impaired kinesthesia of the trunk extensors

    R. Wolke, J. Kuhtz-Buschbeck, G. Deuschl, N. Margraf (Kiel, Germany)

    Objective: In this study the kinesthesia of back Extensors of PD patients with Camptocormia was examined. Background: Camptocormia is a pathological flexion of the trunk…
  • 2019 International Congress

    Effectiveness of exome sequencing in Parkinson’s disease of Chinese population

    YW. Zhao, HX. Pan, L. Jiang, Y. He, Q. Zeng, XT. Zhou, XX. Zhou, LX. Qin, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: The aim of this study was to evaluate rare damaging variants in disease-causing gene of Parkinson’s disease (PD) and other movement disorders, and to…
  • 2019 International Congress

    A Neuroscientific approach for MCI Characterization using a Motor and Cognitive Dual-Task

    G. Mancioppi, F. Fiorini, M. Timpano Sportiello, E. Rovini, F. Cavallo (Pontedera, Italy)

    Objective: To investigate the relationship between cognition and motion skills, through an innovative technological tool able to quantify gait parameters, while providing for a Motor…
  • 2019 International Congress

    Differential Item Functioning in the Unified Dyskinesia Rating Scale (UDysRS) based on Duration of Parkinson’s Disease and Dyskinesia

    X. Ren, J. Lin, S. Luo, C. Goetz, G. Stebbins, E. Cubo (Burgos, Spain)

    Objective: To assess differential item functioning (DIF) in the Unified Dyskinesia Rating Scale (UDysRS) to determine if the duration of Parkinson’s Disease (PD) and/or duration…
  • 2019 International Congress

    Effects of the Neuromodulation of Sensorimotor Rhythms on the Event-Related Desynchronization Phenomenon in Parkinson’s Disease

    MD. Del Castillo, JI. Serrano, E. Rodríguez, E. Rocon, JP. Romero, J. Andreo, A. Arroyo, N. Malpica, H. Melero, M. Gil, E. Sanz (Madrid, Spain)

    Objective: The main goal of this work relies on the study of the desynchronization of the sensorimotor rhythms in Parkinson’s disease (PD). Electrophysiological cortical activity…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley